Abstract
Nucleic Acid TherapeuticsVol. 24, No. 6 Meeting Report10th Annual Meeting of the Oligonucleotide Therapeutics SocietySan Diego, California | October 12–15, 2014Session SummariesKeith T. Gagnon, Jonathan K. Watts, and on behalf of the Board of the Oligonucleotide Therapeutics SocietyKeith T. GagnonSearch for more papers by this author, Jonathan K. WattsSearch for more papers by this author, and on behalf of the Board of the Oligonucleotide Therapeutics SocietySearch for more papers by this authorPublished Online:3 Dec 2014https://doi.org/10.1089/nat.2014.1502AboutSectionsView articleView Full TextPDF/EPUB ToolsPermissionsDownload CitationsTrack CitationsAdd to favorites Back To Publication ShareShare onFacebookTwitterLinked InRedditEmail View articleFiguresReferencesRelatedDetailsCited ByAdvances in Nanoparticle Drug Delivery Systems for Anti-Hepatitis B Virus Therapy: A Narrative Review18 October 2021 | International Journal of Molecular Sciences, Vol. 22, No. 20Chemical Synthesis and Biological Application of Modified Oligonucleotides31 March 2020 | Bioconjugate Chemistry, Vol. 31, No. 5The chemical evolution of oligonucleotide therapies of clinical utility27 February 2017 | Nature Biotechnology, Vol. 35, No. 3Inhibition of hepatitis C virus in mouse models by lipidoid nanoparticle-mediated systemic delivery of siRNA against PRK2Nanomedicine: Nanotechnology, Biology and Medicine, Vol. 12, No. 6The role of helper lipids in lipid nanoparticles (LNPs) designed for oligonucleotide deliveryAdvanced Drug Delivery Reviews, Vol. 99Inhibition of Hepatitis C Virus in Mice by a Small Interfering RNA Targeting a Highly Conserved Sequence in Viral IRES Pseudoknot11 January 2016 | PLOS ONE, Vol. 11, No. 1Emerging Advances in the Management of Cardiac Amyloidosis15 September 2015 | Current Cardiology Reports, Vol. 17, No. 11Oligonucleotide therapeutics: chemistry, delivery and clinical progressFuture Medicinal Chemistry, Vol. 7, No. 16Concise postsynthetic preparation of oligonucleotide–oligopeptide conjugates through facile disulfide bond formationFuture Medicinal Chemistry, Vol. 7, No. 13Hepatitis B virus therapy: What’s the future holding for us?World Journal of Gastroenterology, Vol. 21, No. 44 Volume 24Issue 6Dec 2014 InformationCopyright 2014, Mary Ann Liebert, Inc.To cite this article:Keith T. Gagnon, Jonathan K. Watts, and on behalf of the Board of the Oligonucleotide Therapeutics Society.10th Annual Meeting of the Oligonucleotide Therapeutics Society.Nucleic Acid Therapeutics.Dec 2014.428-434.http://doi.org/10.1089/nat.2014.1502Published in Volume: 24 Issue 6: December 3, 2014PDF download
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
